Fundamental Research set a C$86.76 target price on Bank of Nova Scotia (TSE:BNS – Get Rating) (NYSE:BNS) in a research note published on Tuesday morning, BayStreet.CA reports. The firm currently has a buy rating on the bank’s stock.
Other research analysts have also recently issued research reports about the company. Credit Suisse Group cut their target price on Bank of Nova Scotia to C$73.00 in a research report on Tuesday, November 22nd. Royal Bank of Canada cut their target price on Bank of Nova Scotia from C$86.00 to C$77.00 and set a sector perform rating on the stock in a research report on Wednesday, March 1st. CIBC cut their target price on Bank of Nova Scotia from C$80.00 to C$77.00 in a research report on Wednesday, March 1st. Barclays cut their target price on Bank of Nova Scotia from C$84.00 to C$78.00 in a research report on Wednesday, March 1st. Finally, Keefe, Bruyette & Woods cut their price objective on Bank of Nova Scotia from C$75.00 to C$74.00 in a research report on Wednesday, November 30th. One analyst has rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Bank of Nova Scotia currently has an average rating of Hold and an average target price of C$78.09.
Bank of Nova Scotia Stock Up 0.4 %
Shares of TSE:BNS opened at C$66.00 on Tuesday. The stock has a market cap of C$78.54 billion, a price-to-earnings ratio of 9.34, a PEG ratio of 2.41 and a beta of 0.94. Bank of Nova Scotia has a 12-month low of C$63.19 and a 12-month high of C$94.17. The business’s 50 day moving average is C$70.26 and its 200 day moving average is C$68.77.
Bank of Nova Scotia Dividend Announcement
Bank of Nova Scotia Company Profile
The Bank of Nova Scotia engages in the provision of various banking products and services in Canada, the United States, Mexico, Peru, Chile, Colombia, the Caribbean and Central America, and internationally. It operates through four segments: Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets.
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Bank of Nova Scotia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank of Nova Scotia and related companies with MarketBeat.com's FREE daily email newsletter.